Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ezetimibe + pitavastatin calcium
- Development stage
- Phase 1
- Lead developer
- Kowa
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**AJU-C711** is a fixed-dose combination drug consisting of **ezetimibe** and **pitavastatin calcium**, being developed by AJU Pharm for the treatment of hypercholesterolemia. Ezetimibe functions primarily as a *cholesterol absorption inhibitor*, acting via inhibition of the NPC1L1 protein, while pitavastatin calcium is an *HMG-CoA reductase inhibitor*, reducing cholesterol biosynthesis in the liver. The drug is classified under *antihyperlipidaemics*, *azetidines*, *carboxylic acids*, *cyclopropanes*, *fluorobenzenes*, *propanols*, *quinolines*, and *small molecules*. AJU-C711 completed Phase I clinical trials for hypercholesterolemia in April 2025[1][4][10].
- Brand names
- AJU-C711AJU-C-711AJU-C 711
- Other names
- ezetimibe/pitavastatin calcium
02
Targets
ANPEP (Aminopeptidase N)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)NPC1L1 (Niemann-pick C1-Like 1 transporter)
Beyond the preview
Go deeper on ezetimibe + pitavastatin calcium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ezetimibe + pitavastatin calcium.